Avadel Pharmaceuticals (AVDL) Profit After Tax: 2009-2021
Historic Profit After Tax for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Dec 2021 value amounting to -$23.1 million.
- Avadel Pharmaceuticals' Profit After Tax fell 105.14% to -$23.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$88.2 million, marking a year-over-year decrease of 157.73%. This contributed to the annual value of -$85.5 million for FY2021, which is 1317.22% down from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Profit After Tax of -$23.1 million as of Q4 2021, which was up 9.85% from -$25.7 million recorded in Q3 2021.
- In the past 5 years, Avadel Pharmaceuticals' Profit After Tax ranged from a high of $28.9 million in Q2 2017 and a low of -$63.9 million during Q4 2018.
- Its 3-year average for Profit After Tax is -$13.0 million, with a median of -$11.5 million in 2020.
- Per our database at Business Quant, Avadel Pharmaceuticals' Profit After Tax surged by 527.70% in 2017 and then plummeted by 2,598.96% in 2021.
- Quarterly analysis of 5 years shows Avadel Pharmaceuticals' Profit After Tax stood at -$8.2 million in 2017, then slumped by 674.52% to -$63.9 million in 2018, then soared by 95.71% to -$2.7 million in 2019, then plummeted by 311.76% to -$11.3 million in 2020, then slumped by 105.14% to -$23.1 million in 2021.
- Its last three reported values are -$23.1 million in Q4 2021, -$25.7 million for Q3 2021, and -$23.3 million during Q2 2021.